Oncodesign announced the creation of its new “Artificial Intelligence” Business Unit.

The board appointed Appoints Stéphane Gerart as its Head. Stéphane Gerart is joining our senior management team to oversee this new business unit. Stéphane will bring his solid experience in medical data processing and artificial intelligence, and he will support our rapid development as the company embark on a key period of expansion. Stéphane Gerart a trained engineer and graduate of the prestigious École Polytechnique research school after majoring in biology at the INA-PG life sciences institution, wrote an academic research thesis on immunology at the Necker-Enfants Malades hospital in Paris concerning immune deficiencies of genetic origin under the supervision of Prof. Alain Fisher. .